Complex Made Simple

Gulf Biotech to set up insulin factory in Bahrain

Bahrain-based Gulf Biotech Co has announced construction work on its new insulin factory in the country is soon to commence, Gulf Daily News has reported. The $93m plant will come up on a 16,000 sq m site in Salman Industrial City, said Gulf Biotech chief executive, Dr Riyadh Al Ashban. "The plant is expected to start operations by mid-2015 with an initial production capacity of 42 million units," said Al Ashban.